News | December 21, 2008

Physician Prescriptions for LifeVest Wearable Defibrillator Top 12,000

December 22, 2008 - ZOLL Medical Corp. recently said more than 12,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the ZOLL LifeVest Wearable Defibrillator by their physician since it was approved by the FDA in 2002.

The company said this represents more than 2,000 years of cumulative patient time wearing a LifeVest, and, in any given month, more than 1,000 patients are being protected from sudden death wearing the LifeVest, Zoll said.

LifeVest is a wearable defibrillator that has a 98 percent first shock success rate for treating patients with SCA. In addition, no bystander intervention is required, the company said. The non-invasive technology continuously monitors the patient’s heart and, if a life-threatening heart rhythm is detected, the device alerts the patient prior to delivering a shock. The device releases a conductive gel onto the therapy electrodes to protect the skin, and then delivers a shock to restore normal heart rhythm. The entire event, from detecting a life-threatening arrhythmia to automatically delivering a defibrillation shock, usually occurs in less than a minute. Timely defibrillation is the single most important factor in saving a SCA victim’s life.

There are two main components to the LifeVest: a garment and a monitor. The garment is worn under clothing and records arrhythmias, including before and after treatment. If it detects a life-threatening rhythm, the device alerts the patient to allow a conscious patient to prevent the shock. If the patient is unconscious, the device delivers an electric shock to attempt to restore normal rhythm. The lightweight monitor weighs about 1.8 pounds and is worn around the waist or from a shoulder strap, making it the only wearable external defibrillator available, the company said. Patients wearing the LifeVest are encouraged to wear the device continuously, excluding time when bathing or showering.

Additionally, patients can connect the LifeVest monitor to a telephone modem, and transmit their heart monitoring data to the LifeVest Network, where their physicians can review the data.

For more information: www.zoll.com


Related Content

News | Defibrillator Monitors

July 28, 2023 — GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to ...

Home July 28, 2023
Home
News | Defibrillator Monitors

August 3, 2022 — A defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances ...

Home August 03, 2022
Home
News | Defibrillator Monitors

August 1, 2022 — A study from the University of Warwick has found that school-based defibrillators (AEDs) that are ...

Home August 01, 2022
Home
News | Defibrillator Monitors

June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for ...

Home June 23, 2020
Home
News | Defibrillator Monitors

April 24, 2020 — The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and ...

Home April 24, 2020
Home
News | Defibrillator Monitors

January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 ...

Home January 13, 2020
Home
Technology | Defibrillator Monitors

June 19, 2019 — Philips announced the U.S. Food and Drug Administration (FDA) has approved the company’s premarket ...

Home June 19, 2019
Home
News | Defibrillator Monitors

April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the 2019 American College ...

Home April 05, 2019
Home
Feature | Defibrillator Monitors

February 4, 2019 — Stryker announced Feb. 1, the company is launching a voluntary field action on specific units of the ...

Home February 04, 2019
Home
Feature | Defibrillator Monitors | Michael J. Mirro, M.D.

Following the Vest Prevention of Early Sudden Death Trial (VEST) presentation at the 2018 American College of Cardiology ...

Home July 10, 2018
Home
Subscribe Now